These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
479 related articles for article (PubMed ID: 8258147)
1. T cell reactivity to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis. Wang ZY; Qiao J; Melms A; Link H Cell Immunol; 1993 Dec; 152(2):394-404. PubMed ID: 8258147 [TBL] [Abstract][Full Text] [Related]
2. Induction of interferon-gamma, interleukin-4, and transforming growth factor-beta in rats orally tolerized against experimental autoimmune myasthenia gravis. Wang ZY; Link H; Ljungdahl A; Höjeberg B; Link J; He B; Qiao J; Melms A; Olsson T Cell Immunol; 1994 Sep; 157(2):353-68. PubMed ID: 7520837 [TBL] [Abstract][Full Text] [Related]
3. Depletion of CD8+ T cells suppresses the development of experimental autoimmune myasthenia gravis in Lewis rats. Zhang GX; Ma CG; Xiao BG; Bakhiet M; Link H; Olsson T Eur J Immunol; 1995 May; 25(5):1191-8. PubMed ID: 7774622 [TBL] [Abstract][Full Text] [Related]
4. B cell responses to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis. Wang ZY; Huang J; Olsson T; He B; Link H J Neurol Sci; 1995 Feb; 128(2):167-74. PubMed ID: 7537794 [TBL] [Abstract][Full Text] [Related]
5. Oral administration of acetylcholine receptor: effects on experimental myasthenia gravis. Okumura S; McIntosh K; Drachman DB Ann Neurol; 1994 Nov; 36(5):704-13. PubMed ID: 7979216 [TBL] [Abstract][Full Text] [Related]
6. Protective potential of experimental autoimmune myasthenia gravis in Lewis rats by IL-10-modified dendritic cells. Duan RS; Adikari SB; Huang YM; Link H; Xiao BG Neurobiol Dis; 2004 Jul; 16(2):461-7. PubMed ID: 15193302 [TBL] [Abstract][Full Text] [Related]
7. The limitation of IL-10-exposed dendritic cells in the treatment of experimental autoimmune myasthenia gravis and myasthenia gravis. Xiao BG; Duan RS; Zhu WH; Lu CZ Cell Immunol; 2006 Jun; 241(2):95-101. PubMed ID: 17005165 [TBL] [Abstract][Full Text] [Related]
8. Specificity of the T cell immune response to acetylcholine receptor in experimental autoimmune myasthenia gravis. Response to subunits and synthetic peptides. Fujii Y; Lindstrom J J Immunol; 1988 Mar; 140(6):1830-7. PubMed ID: 2450133 [TBL] [Abstract][Full Text] [Related]
9. Role for interferon-gamma in rat strains with different susceptibility to experimental autoimmune myasthenia gravis. Wang HB; Shi FD; Li H; van der Meide PH; Ljunggren HG; Link H Clin Immunol; 2000 May; 95(2):156-62. PubMed ID: 10779409 [TBL] [Abstract][Full Text] [Related]
10. Suppression of experimental autoimmune myasthenia gravis by nasal administration of acetylcholine receptor. Ma CG; Zhang GX; Xiao BG; Link J; Olsson T; Link H J Neuroimmunol; 1995 Apr; 58(1):51-60. PubMed ID: 7537280 [TBL] [Abstract][Full Text] [Related]
11. Cellular mRNA expression of interferon-gamma (IFN-gamma), IL-4 and transforming growth factor-beta (TGF-beta) in rats nasally tolerized against experimental autoimmune myasthenia gravis (EAMG). Ma CG; Zhang GX; Xiao BG; Link H Clin Exp Immunol; 1996 Jun; 104(3):509-16. PubMed ID: 9099937 [TBL] [Abstract][Full Text] [Related]
12. Mucosal tolerance to experimental autoimmune myasthenia gravis is associated with down-regulation of AChR-specific IFN-gamma-expressing Th1-like cells and up-regulation of TGF-beta mRNA in mononuclear cells. Ma CG; Zhang GX; Xiao BG; Wang ZY; Link J; Olsson T; Link H Ann N Y Acad Sci; 1996 Feb; 778():273-87. PubMed ID: 8610980 [TBL] [Abstract][Full Text] [Related]
13. Suppression of experimental myasthenia gravis by a B-cell epitope-free recombinant acetylcholine receptor. Yi HJ; Chae CS; So JS; Tzartos SJ; Souroujon MC; Fuchs S; Im SH Mol Immunol; 2008 Nov; 46(1):192-201. PubMed ID: 18799218 [TBL] [Abstract][Full Text] [Related]
14. The role of B-cells in experimental myasthenia gravis in mice. Wang HB; Li H; He B; Bakheit M; Levi M; Wahren B; Berglöf A; Sandstedt K; Link H; Shi FD Biomed Pharmacother; 1999 Jun; 53(5-6):227-33. PubMed ID: 10424244 [TBL] [Abstract][Full Text] [Related]
15. T-cell immunity to acetylcholine receptor and its subunits in Lewis rats over the course of experimental autoimmune myasthenia gravis. Wang ZY; Link H; Huang WX Scand J Immunol; 1993 May; 37(5):615-22. PubMed ID: 7683442 [TBL] [Abstract][Full Text] [Related]
16. B cell autoimmunity to acetylcholine receptor and its subunits in Lewis rats over the course of experimental autoimmune myasthenia gravis. Wang ZY; Link H; Qiao J; Olsson T; Huang WX J Neuroimmunol; 1993 Jun; 45(1-2):103-12. PubMed ID: 8331155 [TBL] [Abstract][Full Text] [Related]
17. Autoreactive T cell responses and cytokine patterns reflect resistance to experimental autoimmune myasthenia gravis in Wistar Furth rats. Zhang GX; Ma CG; Xiao BG; van de Meide PH; Link H Eur J Immunol; 1996 Nov; 26(11):2552-8. PubMed ID: 8921938 [TBL] [Abstract][Full Text] [Related]
18. Mice with IFN-gamma receptor deficiency are less susceptible to experimental autoimmune myasthenia gravis. Zhang GX; Xiao BG; Bai XF; van der Meide PH; Orn A; Link H J Immunol; 1999 Apr; 162(7):3775-81. PubMed ID: 10201893 [TBL] [Abstract][Full Text] [Related]
19. Nasal tolerance in experimental autoimmune myasthenia gravis (EAMG): induction of protective tolerance in primed animals. Shi FD; Bai XF; Li HL; Huang YM; Van der Meide PH; Link H Clin Exp Immunol; 1998 Mar; 111(3):506-12. PubMed ID: 9528890 [TBL] [Abstract][Full Text] [Related]
20. Animal models of myasthenia gravis. Christadoss P; Poussin M; Deng C Clin Immunol; 2000 Feb; 94(2):75-87. PubMed ID: 10637092 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]